Optimising Supply Chain & Manufacturing Strategies to Scale Obesity Therapeutics, Reduce Costs & Expand Patient Access
- Evaluating the key challenges of maintaining a robust and efficient supply chain to identify strategies to meet the increased demand of weight loss therapeutics
- Exploring opportunities to decrease peptide manufacturing complexity to reduce COGs and allow seamless commercial scale up
- Highlighting manufacturing and development innovation to expanding patient access and secure long-term commercial viability
- Utilising biological processes to decrease solvent use and enhance sustainable drug development